Panel discussion

Open Access

Panel discussion

Session: New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Topic: Treatment

Speaker: Professor G. Filippatos (Athens, GR) Professor J. Butler (Dallas, US) Professor M. Packer (Dallas, US) Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speakers

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

77 presentations

11 followers

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

116 presentations

18 followers

Professor Milton Packer

Baylor University Medical Center, Dallas (United States of America)

59 presentations

17 followers

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

171 presentations

11 followers

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

103 presentations

4 followers

4 more presentations in this session

Introduction.

Speaker: Professor J. Butler (Dallas, US)

Access

Video

EMPEROR-REDUCED Trial: main results.

Speaker: Doctor M. Packer (Dallas, US)

Access

Video

SGLT2 inhibitors in HFrEF, a meta-analytical approach.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access

Video

Conclusion.

Speaker: Professor M. Packer (Dallas, US)

Access

Video

Access the full session

New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Speakers: Professor G. Filippatos, Professor J. Butler, Professor M. Packer, Professor S. Anker, Professor F. Zannad...

Access

Video

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources